Targeting pulmonary tumor microenvironment with CXCR4-inhibiting nanocomplex to enhance anti–PD-L1 immunotherapy

Journal: Science Advances

Published: 2020-05-01

DOI: 10.1126/sciadv.aaz9240

Affiliations: 4

Authors: 6

Go to article
Institutions Share
State Key Laboratory of Natural Medicines (SKLNM), CPU, China 0.42
China Pharmaceutical University (CPU), China 0.42
University of Nebraska Medical Center (UNMC), United States of America (USA) 0.17